CARMAT revenue breakdown overview

CARMAT revenue for the last year amounted to 3.09 M USD, the most of which — 3.09 M USD — came from its highest performing source at the moment, Orthotropic and Biocompatible Artificial Heart, the year earlier bringing 369.24 k USD. The greatest contribution to the revenue figure was made by France — last year it brought CARMAT 3.09 M USD, and the year before that — 369.24 k USD.